Informações:
Falhas:
ID
15274
Descrição
Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00237211
Link
https://clinicaltrials.gov/show/NCT00237211
Palavras-chave
Versões (1)
- 24/05/2016 24/05/2016 -
Transferido a
24 de maio de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Postmenopausal Women With Advanced Breast Cancer NCT00237211
Eligibility Postmenopausal Women With Advanced Breast Cancer NCT00237211
- StudyEvent: Eligibility
Similar models
Eligibility Postmenopausal Women With Advanced Breast Cancer NCT00237211
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
breast cancer
Item
patients with histologically documented breast cancer.
boolean
C0678222 (UMLS CUI [1])
hormone receptor status
Item
patients with hormone receptor (er and/or pgr) status of positive or unknown
boolean
C0019929 (UMLS CUI [1])
amenorrheic
Item
patients who have been amenorrheic for the preceding 12 months or more.
boolean
C0002453 (UMLS CUI [1])
age
Item
patients who are 20 years or older and younger than 75 years.
boolean
C0001779 (UMLS CUI [1])
therapeutic procedures
Item
patients with a history of postoperative adjuvant therapy or a history of endocrine therapy with tamoxifen for the treatment of progression or recurrence of the lesion. the endocrine therapy, however, should not exceed one regimen.
boolean
C0087111 (UMLS CUI [1])
progressing lesions
Item
patients with progressing lesions.
boolean
C0221198 (UMLS CUI [1,1])
C0205329 (UMLS CUI [1,2])
C0205329 (UMLS CUI [1,2])
sufficient organ function
Item
patients with sufficient organ function to evaluate the safety
boolean
C1254358 (UMLS CUI [1,1])
C0205410 (UMLS CUI [1,2])
C0205410 (UMLS CUI [1,2])
performance status
Item
patients whose performance status (ps) is classified in 0～2.
boolean
C1520224 (UMLS CUI [1])
ID.9
Item
patients who have no residual effects from previous treatments
boolean
malignant disease
Item
patients with other concurrent or previous malignant disease (excluding uterine carcinoma in-situ).
boolean
C0006826 (UMLS CUI [1])
hypercalcemia and uncontrollable cardiac disease
Item
patients with hypercalcemia and uncontrollable cardiac disease (including a history of serious cardiac disease)
boolean
C0020437 (UMLS CUI [1])
C0018799 (UMLS CUI [2])
C0018799 (UMLS CUI [2])
aromatase inhibitor
Item
patients who have previously received aromatase inhibitor.
boolean
C0593802 (UMLS CUI [1])
lymphangitis-type lung metastasis or symptomatic brain metastasis
Item
patients who have lymphangitis-type lung metastasis or symptomatic brain metastasis.
boolean
C0153676 (UMLS CUI [1])
C0220650 (UMLS CUI [2])
C0220650 (UMLS CUI [2])
other inclusion criteria
Item
other protocol-defined inclusion / exclusion criteria may apply.
boolean
C1512693 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])